<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Funnell T</submitter><funding>Cancer Research UK</funding><funding>NCI NIH HHS</funding><pagination>106-115</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9712114</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>612(7938)</volume><pubmed_abstract>How cell-to-cell copy number alterations that underpin genomic instability&lt;sup>1&lt;/sup> in human cancers drive genomic and phenotypic variation, and consequently the evolution of cancer&lt;sup>2&lt;/sup>, remains understudied. Here, by applying scaled single-cell whole-genome sequencing&lt;sup>3&lt;/sup> to wild-type, TP53-deficient and TP53-deficient;BRCA1-deficient or TP53-deficient;BRCA2-deficient mammary epithelial cells (13,818 genomes), and to primary triple-negative breast cancer (TNBC) and high-grade serous ovarian cancer (HGSC) cells (22,057 genomes), we identify three distinct 'foreground' mutational patterns that are defined by cell-to-cell structural variation. Cell- and clone-specific high-level amplifications, parallel haplotype-specific copy number alterations and copy number segment len</pubmed_abstract><journal>Nature</journal><pubmed_title>Single-cell genomic variation induced by mutational processes in cancer.</pubmed_title><pmcid>PMC9712114</pmcid><funding_grant_id>K99 CA256508</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><pubmed_authors>Grewal D</pubmed_authors><pubmed_authors>Greenwood W</pubmed_authors><pubmed_authors>Moore RA</pubmed_authors><pubmed_authors>Shah SP</pubmed_authors><pubmed_authors>Pham J</pubmed_authors><pubmed_authors>Ceglia N</pubmed_authors><pubmed_authors>Lim JLP</pubmed_authors><pubmed_authors>Biele J</pubmed_authors><pubmed_authors>Williams E</pubmed_authors><pubmed_authors>Uhlitz F</pubmed_authors><pubmed_authors>Alon S</pubmed_authors><pubmed_authors>Funnell T</pubmed_authors><pubmed_authors>Walton NA</pubmed_authors><pubmed_authors>Liu YF</pubmed_authors><pubmed_authors>O'Flanagan CH</pubmed_authors><pubmed_authors>Abrams D</pubmed_authors><pubmed_authors>Gonzalez-Fernandez C</pubmed_authors><pubmed_authors>Van Vliet M</pubmed_authors><pubmed_authors>Wassie AT</pubmed_authors><pubmed_authors>Bruna A</pubmed_authors><pubmed_authors>Eirew P</pubmed_authors><pubmed_authors>Battistoni G</pubmed_authors><pubmed_authors>IMAXT Consortium</pubmed_authors><pubmed_authors>Zamarin D</pubmed_authors><pubmed_authors>Burger M</pubmed_authors><pubmed_authors>Karagiannis ED</pubmed_authors><pubmed_authors>Grimaldo F</pubmed_authors><pubmed_authors>Zheng P</pubmed_authors><pubmed_authors>Xu H</pubmed_authors><pubmed_authors>de Algara TR</pubmed_authors><pubmed_authors>Fisher E</pubmed_authors><pubmed_authors>Llanos VC</pubmed_authors><pubmed_authors>Boyden ES</pubmed_authors><pubmed_authors>Shea A</pubmed_authors><pubmed_authors>Weiner AC</pubmed_authors><pubmed_authors>Qosaj F</pubmed_authors><pubmed_authors>Miller N</pubmed_authors><pubmed_authors>Casbolt H</pubmed_authors><pubmed_authors>Tietscher S</pubmed_authors><pubmed_authors>Lee M</pubmed_authors><pubmed_authors>Hannon GJ</pubmed_authors><pubmed_authors>Lee H</pubmed_authors><pubmed_authors>Beatty S</pubmed_authors><pubmed_authors>Roth A</pubmed_authors><pubmed_authors>Zaikova E</pubmed_authors><pubmed_authors>Douglas JM</pubmed_authors><pubmed_authors>Fan J</pubmed_authors><pubmed_authors>Chornay N</pubmed_authors><pubmed_authors>Rueda OM</pubmed_authors><pubmed_authors>Huntsman DG</pubmed_authors><pubmed_authors>Kabeer F</pubmed_authors><pubmed_authors>Balasubramanian S</pubmed_authors><pubmed_authors>McPherson A</pubmed_authors><pubmed_authors>Bodenmiller B</pubmed_authors><pubmed_authors>Caldas C</pubmed_authors><pubmed_authors>Pearson I</pubmed_authors><pubmed_authors>Bojilova V</pubmed_authors><pubmed_authors>Cui Y</pubmed_authors><pubmed_authors>Eyal-Lubling Y</pubmed_authors><pubmed_authors>Brimhall J</pubmed_authors><pubmed_authors>Lee SR</pubmed_authors><pubmed_authors>Sawicka K</pubmed_authors><pubmed_authors>Shi H</pubmed_authors><pubmed_authors>Yap D</pubmed_authors><pubmed_authors>Zhang AW</pubmed_authors><pubmed_authors>Sinha A</pubmed_authors><pubmed_authors>Havasov E</pubmed_authors><pubmed_authors>Wang B</pubmed_authors><pubmed_authors>Mulvey CM</pubmed_authors><pubmed_authors>Joyce JA</pubmed_authors><pubmed_authors>Weigelt B</pubmed_authors><pubmed_authors>Watson SS</pubmed_authors><pubmed_authors>Aparicio S</pubmed_authors><pubmed_authors>Gonzalez-Solares EA</pubmed_authors><pubmed_authors>Salehi S</pubmed_authors><pubmed_authors>Masud T</pubmed_authors><pubmed_authors>Kim SH</pubmed_authors><pubmed_authors>Au V</pubmed_authors><pubmed_authors>Dinh KN</pubmed_authors><pubmed_authors>Tavare S</pubmed_authors><pubmed_authors>Xia C</pubmed_authors><pubmed_authors>Laks E</pubmed_authors><pubmed_authors>Vogl SL</pubmed_authors><pubmed_authors>Da Cruz Paula A</pubmed_authors><pubmed_authors>Kuett L</pubmed_authors><pubmed_authors>Nugent F</pubmed_authors><pubmed_authors>Martin SD</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Jauset C</pubmed_authors><pubmed_authors>McKinney S</pubmed_authors><pubmed_authors>Emenari A</pubmed_authors><pubmed_authors>Lai D</pubmed_authors><pubmed_authors>Ribes MP</pubmed_authors><pubmed_authors>Goodwin DR</pubmed_authors><pubmed_authors>Vazquez-Garcia I</pubmed_authors><pubmed_authors>Becker R</pubmed_authors><pubmed_authors>Wild SA</pubmed_authors><pubmed_authors>Dariush A</pubmed_authors><pubmed_authors>Reis-Filho JS</pubmed_authors><pubmed_authors>Williams MJ</pubmed_authors><pubmed_authors>Kovacevic T</pubmed_authors><pubmed_authors>Yoldas AK</pubmed_authors><pubmed_authors>Sepulveda LA</pubmed_authors><pubmed_authors>Bressan D</pubmed_authors><pubmed_authors>Kunes R</pubmed_authors><pubmed_authors>Al Sa'd M</pubmed_authors><pubmed_authors>McAlpine JN</pubmed_authors><pubmed_authors>Windhager J</pubmed_authors><pubmed_authors>Harris O</pubmed_authors><pubmed_authors>Cannell IG</pubmed_authors><pubmed_authors>Smith A</pubmed_authors><pubmed_authors>Harris S</pubmed_authors><pubmed_authors>Zhuang X</pubmed_authors><pubmed_authors>Ting J</pubmed_authors><pubmed_authors>Leventhal E</pubmed_authors><pubmed_authors>Callari M</pubmed_authors><pubmed_authors>Lerda G</pubmed_authors><pubmed_authors>Rusk N</pubmed_authors><pubmed_authors>Leung S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single-cell genomic variation induced by mutational processes in cancer.</name><description>How cell-to-cell copy number alterations that underpin genomic instability&lt;sup>1&lt;/sup> in human cancers drive genomic and phenotypic variation, and consequently the evolution of cancer&lt;sup>2&lt;/sup>, remains understudied. Here, by applying scaled single-cell whole-genome sequencing&lt;sup>3&lt;/sup> to wild-type, TP53-deficient and TP53-deficient;BRCA1-deficient or TP53-deficient;BRCA2-deficient mammary epithelial cells (13,818 genomes), and to primary triple-negative breast cancer (TNBC) and high-grade serous ovarian cancer (HGSC) cells (22,057 genomes), we identify three distinct 'foreground' mutational patterns that are defined by cell-to-cell structural variation. Cell- and clone-specific high-level amplifications, parallel haplotype-specific copy number alterations and copy number segment len</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-25T17:14:53.558Z</modification><creation>2025-04-06T04:55:03.294Z</creation></dates><accession>S-EPMC9712114</accession><cross_references><pubmed>36289342</pubmed><doi>10.1038/s41586-022-05249-0</doi></cross_references></HashMap>